Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.7151
Delayed Data
As of May 01
 -0.0049 / -0.68%
Today’s Change
0.65
Today|||52-Week Range
1.05
+2.16%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash9.9M13.5M18.7M9.8M
 
 
 
 
 
Short Term Investment Cash-2.5M3.6M5.2M-8.9M
 
 
 
 
 
Cash & Short Term Investments11.8M13.6M18.8M32.7M
 
 
 
 
 
 
ReceivablesReceivables18.7K0.000.000.00
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsPrepaid Expenses163.3K12.8K507.2K--
 
 
 
 
Other Current Assets169.9K176.0K0.00731.0K
 
 
 
 
Current Assets12.2M13.8M19.3M33.4M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross665.4K665.4K645.9K687.2K
 
 
 
 
 
Depreciation-570.8K-613.2K-580.7K-609.1K
 
 
 
 
 
Other Assets0.000.000.000.00--
Total Assets13.7M14.9M19.6M33.5M
 
 
 
 
 
 
LiabilitiesAccounts Payable555.6K851.8K251.7K706.8K
 
 
 
 
 
Accrued Expenses500.2K--240.6K1.1M
 
 
 
 
Other Current Liabilities500.2K0.00240.6K1.1M
 
 
 
 
Other Liabilities1.2M851.8K933.8K2.5M
 
 
 
 
 
 
Total LiabilitiesOther Liabilities973.1K4.5M5.1M3.9M
 
 
 
 
 
Total Liabilities3.0M5.4M6.9M7.0M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity10.7M9.5M12.6M26.6M
 
 
 
 
 
Total Shareholder Equity10.7M9.5M12.6M26.6M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding95.3M119.4M146.7M178.3M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.
 

To view my watchlist

Not a member yet?

Sign up now for a free account